XASX
AYA
Market cap83mUSD
Aug 08, Last price
1.13AUD
1D
0.45%
1Q
75.78%
IPO
230.88%
Name
Artrya Ltd
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.14%
Rev. gr., 5y
%
Revenues
0k
Net income
-14m
L+25.72%
CFO
-15m
L+43.48%
Profile
Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. The company was incorporated in 2018 and is based in West Perth, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | 13,806 | 7,459 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (13,806) | (7,459) | ||||
NOPBT Margin | ||||||
Operating Taxes | 27 | 18 | ||||
Tax Rate | ||||||
NOPAT | (13,833) | (7,477) | ||||
Net income | (14,000) 25.72% | (11,136) -35.09% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 12 | 20 | ||||
BB yield | -0.07% | -0.12% | ||||
| Debt | ||||||
Debt current | 325 | 275 | ||||
Long-term debt | 1,573 | 1,874 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 12 | |||||
Net debt | (5,385) | (18,257) | ||||
| Cash flow | ||||||
Cash from operating activities | (15,407) | (10,738) | ||||
CAPEX | (46) | (5,950) | ||||
Cash from investing activities | 2,705 | 15,826 | ||||
Cash from financing activities | (299) | (245) | ||||
FCF | (14,394) | (8,876) | ||||
| Balance | ||||||
Cash | 7,283 | 20,406 | ||||
Long term investments | ||||||
Excess cash | 7,283 | 20,406 | ||||
Stockholders' equity | 16,804 | 30,556 | ||||
Invested Capital | 10,482 | 11,362 | ||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 78,643 | 78,381 | ||||
Price | 0.22 0.00% | 0.22 | ||||
Market cap | 17,301 0.33% | 17,244 | ||||
EV | 11,916 | (1,013) | ||||
EBITDA | (11,811) | (6,907) | ||||
EV/EBITDA | 0.15 | |||||
Interest | 31 | 58 | ||||
Interest/NOPBT | ||||||